Dapoxetine hydrochloride is a selective serotonin reuptake inhibitor and the first drug approved for the on-demand treatment of premature ejaculation (PE). Its safety was established in a thorough clinical development program.
Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study
IAFRATE, MASSIMO
2014
Abstract
Dapoxetine hydrochloride is a selective serotonin reuptake inhibitor and the first drug approved for the on-demand treatment of premature ejaculation (PE). Its safety was established in a thorough clinical development program.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
European Urology 2014.pdf
Accesso riservato
Tipologia:
Published (Publisher's Version of Record)
Licenza:
Accesso privato - non pubblico
Dimensione
346.08 kB
Formato
Adobe PDF
|
346.08 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
